Sutro Biopharma, Inc. (STRO) Reports FY Loss of $1.78

Sutro Biopharma, Inc. (NASDAQ: STRO) reported FY EPS of ($1.78). Revenue for the year came in at $153.73 million.

For earnings history and earnings-related data on Sutro Biopharma, Inc. (STRO) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Pfizer lung cancer drug misses survival goal in Phase 3 trial
• Credo Technology pops 3.5% as Evercore initiates with monster $325 price target